Design, synthesis and biological evaluation of novel ketone derivatives containing benzimidazole and 1,3,4-triazole as CA inhibitors
dc.authorid | ISIK, Aysen/0000-0002-1280-0019 | |
dc.contributor.author | Cevik, Ulviye Acar | |
dc.contributor.author | Isik, Aysen | |
dc.contributor.author | Kapavarapu, Ravikumar | |
dc.contributor.author | Kucukoglu, Kaan | |
dc.contributor.author | Nadaroglu, Hayrunnisa | |
dc.contributor.author | Bostanci, Hayrani Eren | |
dc.contributor.author | Ozkay, Yusuf | |
dc.date.accessioned | 2025-05-04T16:47:08Z | |
dc.date.available | 2025-05-04T16:47:08Z | |
dc.date.issued | 2024 | |
dc.department | Sivas Cumhuriyet Üniversitesi | |
dc.description.abstract | In this study, we synthesized a series of new benzimidazole-triazole (6a-6k) derivatives and characterized them by 1H NMR, 13C NMR, and HRMS. These compounds were evaluated for their inhibitory activity against hCA-I and hCA-II. All the compounds exhibited good hCA-I and hCA-II inhibitory activities with IC50 values in the range of 1.158 mu M to 3.48 mu M. Among all these compounds, compound 6j, with an IC50 value of 1.288 mu M and 1.6197 mu M, is the most active against hCA-I and hCA-II, respectively. Compounds 6a-6k were also evaluated for their cytotoxic effects on the L929 mouse fibroblast (normal) cell line. Enzyme inhibition kinetics showed all compounds 6a-6k to inhibit the enzyme by non-competitive. The most active compound 6j was subjected to molecular docking, which revealed their binding interactions with the enzyme's active site, confirming the experimental findings. | |
dc.identifier.doi | 10.1016/j.molstruc.2023.136770 | |
dc.identifier.issn | 0022-2860 | |
dc.identifier.issn | 1872-8014 | |
dc.identifier.scopus | 2-s2.0-85173844631 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.uri | https://doi.org/10.1016/j.molstruc.2023.136770 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12418/35491 | |
dc.identifier.volume | 1295 | |
dc.identifier.wos | WOS:001097119900001 | |
dc.identifier.wosquality | Q2 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.language.iso | en | |
dc.publisher | Elsevier | |
dc.relation.ispartof | Journal of Molecular Structure | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.snmz | KA_WOS_20250504 | |
dc.subject | Benzimidazole | |
dc.subject | 4-Triazole | |
dc.subject | Carbonic anhydrase | |
dc.subject | Molecular docking | |
dc.subject | Cytotoxicity | |
dc.title | Design, synthesis and biological evaluation of novel ketone derivatives containing benzimidazole and 1,3,4-triazole as CA inhibitors | |
dc.type | Article |